Patient Compliance

A fund developed by Saskatchewan pharmacists to develop and support alternative reimbursement programs is being tapped this year to support the minor ailment assessment program.

OTTAWA | The manufacturer of a drug used to treat multiple sclerosis is issuing new safety recommendations aimed at reducing the risk of serious heart-related side-effects when patients first start taking the medication.

Here are motions passed by the ‘Parliament of Canadian medicine’

Drug was formerly indicated only for use in the management of hypertension in adults.

For the first time ever, Canada will be fielding a soccer team competing in an international soccer tournament for children living with type 1 diabetes.

Drug is the fourth kinase inhibitor to be approved for treatment of metastatic renal cell carcinoma in Canada.